RT Journal Article
SR Electronic
T1 The epidemiology of autoimmune liver disease varies with geographic latitude
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.27.20141382
DO 10.1101/2020.06.27.20141382
A1 Webb, Gwilym J
A1 Ryan, Ronan P
A1 Marshall, Tom P
A1 Hirschfield, Gideon M
YR 2020
UL http://medrxiv.org/content/early/2020/06/28/2020.06.27.20141382.abstract
AB Background & aims The epidemiology of autoimmune liver disease (AILD) is challenging to study because of the diseases’ rarity and because of cohort selection bias. Increased incidence further from the Equator is reported for multiple sclerosis, another autoimmune. We assessed the incidence of primary biliary cholangitis (PBC), primary biliary cholangitis (PSC), and autoimmune hepatitis (AIH) in relation to latitude.Methods Retrospective cohort study using anonymised UK primary care records 2002-01-01 to 2016-05-10. All adults without a baseline diagnosis of autoimmune liver disease were included and followed until first occurrence of an AILD diagnosis, death, or they left the database. Latitude was measured as registered general practice rounded down to whole degrees.Results The cohort included 8 590 421 records with 53.3 107 years follow-up from 694 practices.There were 1314 incident cases of PBC, 396 of PSC, and 1034 of AIH. Crude incidences (95% confidence interval) was: PBC 2.47 (2.34-2.60), PSC 0.74 (0.67-0.82), and AIH 1.94 (1.83-2.06)/100 000/year. PBC incidence correlated with female sex, smoking, and deprivation; PSC incidence correlated with male sex and not smoking; AIH incidence correlated with female sex and deprivation.More northerly latitude was strongly associated with incidence of PBC: 2.16 (1.79-2.60) to 4.86 (3.93-6.00) from 50-57°N (p=0.002) and AIH 2.00 (1.65-2.43) to 3.28 (2.53-4.24)(p=0.003), but not PSC 0.82 (0.60-1.11) to 1.02 (0.64-1.61)(p=0.473).Incidence after adjustment for age, sex, smoking, and deprivation status showed similar positive correlations for PBC and AIH with latitude, but not PSC. Incident AIH cases were younger at greater latitude.Conclusions We describe a novel association between increased latitude and the incidence of PBC and AIH that requires both confirmation and explanation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGJW and GMH have received support from the National Institute for Health Research Birmingham Biomedical Research Unit. GJW has benefitted from a UK Medical Research Council Clinical Research Fellowship. GMH receives fur- ther support from the UK Medical Research Council funded UK-PBC stratified medicine platform (www.uk-pbc.com), an EU Career Development Award and is also Chief Investigator for UK-PSC (www.uk-psc.com), a NIHR Translational Research Collaboration. TM is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) West Midlands. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. This report presents independent research partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the au- thors and not necessarily those of the NHS, the NIHR or the Department of Health. This report was partly supported by an educational grant from Intercept Pharmaceuticals.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:THIN has previously received approval for research using its database from the NHS South-East Multi-Centre Research Ethics Committee in 2003. This study received approval from the THIN Scientific Review Committee: reference 16THIN055.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData presented may be made available to other researchers in liaison with The Health Improvement Network.